Protease inhibitors for the treatment of hepatitis C virus infection

Protease inhibitors for the treatment of hepatitis C virus infection

The hepatitis C virus (HCV) has affected an estimate of 80 million individuals worldwide and is a strain of public health. Around 25–30% of patients in Europe and the US infected with HIV are coinfected with HCV. Despite treatment modalities containing a NS3/4A protease it in combination with pegyla...

Full description

Bibliographic Details
Main Authors: de Leuw, Philipp, Stephan, Christoph
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2017-11-01
Series:GMS Infectious Diseases
Subjects:
direct-acting antiviral
hepatitis C
HIV
NS3/4A protease inhibitor
Online Access:http://www.egms.de/static/en/journals/id/2017-5/id000034.shtml

Similar Items

Similar Items